News
2011-11-04

As part of the joint program CQDM / Alsace BioValley, the project submitted by Photon Etc., Rhenovia and the Neurophotonics center has been granted.
Development and validation of two synergistic platforms based on imaging and biosimulation to visualize the action of drug candidates at the subcellular and molecular levels.
Québec: Sébastien Blais-Ouellette (Photon Etc.) and Paul De Koninck (Université Laval and Neurophotonics center – Centre de recherche Université Laval Robert-Giffard)
Alsace: Serge Bischoff (Rhenovia Pharma)
$700,000 over 3 years (for the research being performed in Québec)
2011-07-06

2011-05-02
